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Abstract 
 
Adherence to medicines is a major determinant of the effectiveness of medicines.  However, 
estimates of non-adherence in the older-aged with chronic conditions vary from 40 to 75%.  The 
problems caused by non-adherence in the older-aged include residential care and hospital 
admissions, progression of the disease, and increased costs to society.  The reasons for non-
adherence in the older-aged include items related to the medicine (e.g. cost, number of 
medicines, adverse effects) and those related to person (e.g. cognition, vision, depression).  It is 
also known that there are many ways adherence can be increased (e.g. use of blister packs, 
cues).  
 
It is assumed that interventions by allied health professions, including a discussion of adherence, 
will improve adherence to medicines in the older aged but the evidence for this has not been 
reviewed.  There is some evidence that telephone counselling about adherence by a nurse or 
pharmacist does improve adherence, short- and long-term.  However, face-to-face intervention 
counselling at the pharmacy, or during a home visit by a pharmacist, has shown variable results 
with some studies showing improved adherence and some not.  Education programs during 
hospital stays have not been shown to improve adherence on discharge, but education programs 
for subjects with hypertension have been shown to improve adherence.  In combination with an 
education program, both counselling and a medicine review program have been shown to 
improve adherence short-term in the older-aged.  Thus, there are many unanswered questions 
about the most effective interventions to promote adherence.   More studies are needed to 
determine the most appropriate interventions by allied health professions, and these need to 
consider the disease state, demographics, and socio-economic status of the older-aged subject, 
and the intensity and duration of intervention needed.   
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1. Introduction 
 
The effectiveness of treatment with medicines can be divided into two determinants; the efficacy 
of the medicine prescribed and the adherence to the medicine (the subjects’ use of the right 
medicine in the correct dose at the right interval).  In turn, there will be numerous factors that 
contribute to efficacy and adherence.  However, although, it is widely recognized that medicines 
do not work in subjects who do not take them, relatively little attention is paid to adherence to 
medicines, compared to drug efficacy.   
 
The World Health Organization estimates that 50% of patients suffering from chronic diseases in 
the developed world do not take their medicines.[1]  In the older-aged (those aged 65 years and 
over), adherence is a particularly serious problem as this group has an increased burden of 
symptoms and disease, leading to the use of more medicines, and an increased likelihood of non-
adherence.[2]  Ratified estimates of non-adherence in the older-aged with chronic conditions vary 
from 40 to 75%.[2]  These percentages equate to large number of subjects – for instance, in the 
USA, two million older-aged Medicare beneficiaries do not adhere to medicines, simply because 
of the cost of the medicines.[3] 
 
The term compliance, the extent to which a patient’s behaviour matches the prescriber’s advice, 
has largely been replaced by the term adherence in recent years.  Adherence is the extent to 
which the patient’s behaviour matches agreed recommendations from the prescriber.  However, 
the terms ‘compliance’ and ‘adherence’ are often used interchangeable, and in this review, I have 
chosen to use the term adherence to cover both compliance and adherence.  Persistence is the 
duration of the continued use of a named drug, and is usually measured from the refilling 
prescription data.  Concordance is a more complex idea relating to the patient/prescriber 
relationship and the degree to which the prescription represents a shared decision, in which the 
beliefs and preferences of the patient have been taken into consideration.  This review considers 
the role of intervention by an allied health professional rather than by the prescriber/doctor, and 
covers compliance, adherence and persistence, but not concordance; with the term adherence 
being used to cover compliance, adherence and persistence. 
 
The definition of older-aged as ≥ 65 years old is used in this review. Where evidence is not 
available in this group, evidence from subjects with a mean age of ~ 60 years, is considered.  
Emphasis is given to more recent data, and data using large number of participants.  Information 
was obtained from searching for articles written in English from 1990 onwards in Pubmed, 
PsychINFO and CINAHL (EBSCO) for the terms; adherence, compliance, or persistence with 
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older-aged or elderly, and by referring to the bibliography obtained in the resulting 
papers/reviews.  Many of the studies in the area of health professional intervention are not of high 
quality.  Rather than excluding these articles from the review, as would be necessary under a 
systematic review according to the PRISMA criteria,[4] I chose to include all the articles in the 
review with discussion of their shortcomings.  Thus, this is a comprehensive review of all the 
health professional intervention studies with no selection on the basis of quality. 
 
As the last time, adherence to medicines in the older-aged was comprehensive reviewed was 
1995[2], the first part of the present review briefly discusses and updates this topic.  Thus, the 
problems associated with non-adherence in the older-aged, the costs to society and the costs to 
the individual, how age relates to adherence, and the other characteristics of non-adherence to 
medicines in the older-aged, and ways to improve adherence are discussed.  This discussion 
establishes that non-adherence in the older-aged is a major problem.  One approach to improving 
adherence is the intervention by a health profession, and it is assumed that this improves 
adherence to medicines, but the evidence for this in the older-aged has not been 
comprehensively reviewed, to date.  Also, it is not known which type of intervention is the most 
effective.  The emphasis of this review is to consider whether interventions by an allied health 
professional that includes a discussion of adherence do, in fact, improve adherence to medicines 
in the older-aged.  The review establishes that some interventions that include a discussion of 
adherence are effective, and suggests that more research needs to be done to determine the 
best interventions by allied health professionals to improve adherence in the older-aged. 
 
2. The problems associated with non-adherence to medicines 
 
2.1 Residential care (nursing home) and hospital admissions 
Non-adherence in the older-aged, regardless of disease state, is a common cause for residential 
care and hospital admissions.  Back in 1992, it was established by the National Pharmaceutical 
Council (US) that non-adherence to medicines accounts for 23% of nursing home admissions.[5]  
Furthermore imposing a limitation to government payments for medicines increases the 
admissions of the older-aged to residential care.[6] 
 
Eleven percent of hospital admissions in the 65 or older age group are due to non-adherence,[7] 
and this increases to 26% in the 75 years or older age group.[8]  An even bigger percentage (33%) 
of the older-aged undergoing hospitalization has a history of non-adherence.[7]   
 
Non-adherence in the older-aged is mostly intentional (63%) with only 37% being unintentional.[9]  
Cost was the most common cause of the non-adherence leading to the hospital admission 
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(36.5%), and for having a history of non-adherence (27.6%).[9]  In > 70 year olds, cost-related non-
adherence to medicine led to 43% being hospitalized compared to 33%, who did not limit 
adherence due to cost.[3]  Forgetfulness was the second most common reason for non-adherence 
for subjects having a history of non-adherence (21.3%).[9]  For non-adherence leading to hospital 
admission, inadequate instruction (25.4%) was the second most common reason.[9]  Other factors 
associated with an increased risk of hospitalization due to non-adherence included, use of 
numerous medicines, seeing numerous physicians, and female sex.[7] 
 
In addition to having shown that non-adherence in the older-aged is generally associated with 
hospital admissions, non-adherence to specific treatments for several disease states have also 
been shown to increase hospital admissions e.g. heart failure,[10] diabetes,[11] osteoporosis.[12]  
Non-adherence is also associated with fewer physicians’ services, hospital outpatients’ services, 
and hospital care,[12] and this suggests that adherence can be improved by intervention strategies 
with allied health professionals.     
 
It is difficult to change the adherence patterns of subjects, even when they have a history of non-
adherence leading to hospital admission.  Thus, it has been shown that, in a study of 775 patients 
(≥ 65 years of age), increased comorbidity severity and an emergency room visit during the year 
prior to involvement in a health maintenance program was still associated with decreased 
adherence after enrolment in the maintenance program.[13] 
 
2.2 Progression of disease 
Non-adherence may also result in progression of the disease.  In subjects who did not adhere to 
a β-blocker after myocardial infarction, in the Beta Blocker Heart Attack Trial, there was a 2.6 fold 
increased risk of death, in the first year.[14]  In another study of subjects discharged after 
myocardial infarction, the adherence to β-blockers, aspirin, and statins was assessed in subjects 
with mean age of 62-65 years.[15]  Subjects who discontinued their medicines after one month had 
lower one-year survival than those that took one or more of the medicines (88.5% vs 97.7%), and 
similar values were obtained for each of the individual medicines.[15]   
 
Self-reported non-adherence is also associated with progression of disease in subjects with 
coronary artery disease that have not had a myocardial infarction in the previous year.  In the 
Heart and Soul study, participants were asked ‘In the past month, how often did you take your 
medicines as the doctor prescribed’.[16]  Non-adherence was reported by 8.2% of the participants, 
and this was an independent predictor of developing cardiovascular events during the 3.9 years 
of follow-up.[16]  Thus, 22.9% in the non-adherent group developed cardiovascular events, 
compared to 13.8% of the adherent group.[16]   
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In women with osteoporosis, and a mean age of 68.4 years, when they received their first 
prescription (bisphosphonate, calcitonin, or an estradiol), adherence was associated with a lower 
fracture rate.[17]  Another example of progression of disease with non-adherence is that 20% of 
patients, who had partial vision loss as a result of glaucoma, have not been taking their medicine 
on a regular basis.[18] 
 
Subjects who restrict their medicines on the basis of cost have progression of their disease.  
Thus, in adults aged ≥ 70 years old, 32.1% had restricted medicine use because of cost, and 
reported a decline in health status over 2-3 years, compared to those that had not restricted 
medicine use because of cost.[19]  In those with cardiovascular disease, who restricted medicines 
due to cost, there was a higher rates of non-fatal heart attacks or strokes.[19]   
 
Even non-adherence to placebo pills may increase mortality.  Thus, in the Canadian Amiodarone 
Myocardial Infarction Arrhythmia Trial (CAMIAT), non-adherence to placebo or amiodarone in 63 
year olds was associated with increased mortality.[20]  This phenomenon has been observed in 
several other studies (in younger subjects).  It has been suggested that there is an association 
between the good adherence to placebo and reduced mortality due to a “healthy adherer” effect, 
whereby adherence to drug therapy may be a surrogate for overall healthy behaviour.[21] The 
converse of this is that non-adherence to placebo may be an indicator of non-adherence to other 
medications, and lead to increased mortality, although (to my knowledge) this has not been 
directly tested to date. 
 
3. The costs associated with non-adherence to medicines 
 
 3.1 Costs to society 
In addition to hospitalisations, re-hospitalisations and residential care admissions are direct costs 
to society of non-adherence in the older-aged.  In many cases, it seems likely that the costs of 
improving adherence will be repaid by savings in health care utilisation and/or improvements in 
health outcomes.  
 
In the older-aged (≥ 65 years old) with type 2 diabetes, it has been estimated that for a 10% 
increase in medicine possession ratio (days of prescription divided by number of days between 
prescription refills x 100) from baseline, there is about a 20% decrease in annual cost.[13]  In older-
aged subjects (mean age of 74 years) with overactive bladder syndrome, increased medicine 
possession rate for antimuscarinic drugs is associated with decreased health care costs.[22]  Thus, 
for a 10% increase in medicine possession ratio, there is a 5.6% decrease in costs.[22]   
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Non-adherence also leads to medicine wastage and there is a cost associated with this.  In a 
large population, 63% of the returned drugs for destruction were from subjects 65 years or 
older.[23]  In retirement community residents, the wastage of medicines is relative small; 2.3%.[24]  
However, this equates to US national cost of over $1 billion per year.[24] 
 
 3.2 Cost to the individual 
Cost is a significant cause of under use with some older-aged people on limited fixed incomes 
making decisions about which drugs they can afford.  In subjects with coronary heart disease or a 
history of myocardial infarction, a number of drugs have been shown to decrease mortality and 
morbidity.  However, there drugs are underutilised in the poor.  For instance, in the US, the use of 
statins, β-blockers and nitrates in adults aged 66 years or older is much less in those who have to 
pay for their prescriptions out-of-pocket than in those with medical insurance covering drug 
costs.[25, 26]  Similarly, the continuing use of drugs to reduce plasma glucose is necessary to 
prevent the morbidity and mortality associated with diabetes, but these drugs are often cut back 
by people on low incomes.[27]  Also, those on low income spend less on food, heat or other basic 
needs to meet the costs of medicines for their diabetes.[27]   
 
Low income is associated with low adherence, irrespective of disease state.  In a large population 
group of non-institutionalized ≥ 65 years, 19% on low incomes did not fill all their prescriptions 
due to cost, and 21% on low incomes skipped doses to make prescriptions last longer.[28] 
 
Trust in the physician also has a role in determining whether subjects will spend money on 
medicines.  Those with low trust in their physician are more likely to forego medicines because of 
cost pressures.[28]  Regardless of level of trust in their physician, subjects with depression were 
more likely to have cost-related medicine underuse than those without depression.[29]   
 
When the cost to the older-aged subject is kept relatively low, there is minimal effect on 
adherence.  In British Columbia (Canada) a system with full drug coverage was replaced with 
patient copayment or coinsurance schemes, and this was associated with only a minimal 
reduction in the adherence to β-blockers in the older aged after a myocardial infarction.[30]    
 
4. Age and adherence 
 
Age alone may not be an important predictor of medicine adherence.  For instance, age was 
shown not to be a predictor of medicine non-adherence in 785 subjects with osteoporosis and a 
mean age of 74 years.[31]  However, with increasing age, patients tend to use more medicines and 
 8
are more likely to be incapacitated by deficits in physical dexterity, cognitive skill and memory, 
along with the medicine being perceived as unnecessary.[2]  Other physical problems may hinder 
adherence.  For instance, the need to be able to lift arms above their head, in order to administer 
eye drops may be difficult for some older-aged people.[32]   
 
Adherence may actually increase with age in some disease states.  In subjects with rheumatoid 
arthritis, adherence to medicines increases with age.[33]  In this group of subjects, the older-aged 
(> 55 year olds) made fewer adherence errors, and the middle-aged (35-44 years old) made the 
most.[33]  Similarly, in 4068 subjects with prescriptions for hypertension (excluding those in 
hospital or nursing home), adherence in subjects ≥ 85 years is greater than in those 75 to 84 
years, which in turn was greater than in those 65 to 74 years old.[34]  However, in subjects taking 
statins, persistence decreased to a small extent at 75 years of age or older.[35] 
 
Non-adherence generally converts into adherence when older-aged people enter residential care 
and the responsibility for adherence becomes that of the carer.  Indeed, adherence in the oldest 
older-aged people may be greater in those that are being looked after by caregivers in hospitals 
or residential care than in older-aged people who are at home.  Thus, in a large study of older-
aged people (≥ 65-99 years old) started on digoxin for heart failure, only 10% filled enough 
prescriptions to have digoxin throughout the year.[36]  However, adherence was higher in patients 
over 85 years of age, probably because they were more likely to have caregiver assistance.[36]  
Adherence was also higher in the older-aged in hospital or residential care stays.[36] 
 
5. The other characteristics of non-adherence  
 
An excellent review of the characteristics of non-adherence in the older-aged was published in 
1995.[2]  These characteristics have been updated, with characteristics that increase non-
adherence the older-aged listed in Table 1, and characteristics that increase adherence in Table 
2.    
 
Table 1: Characteristics, other than cost, which increase non-adherence 
 
Non-adherence increases with Reference/s 
(i) Related to medicine/medication  
Increasing numbers of medicines 37  
Increasing number and severity of adverse effects 2 
Poor communication skills of prescriber 2 
The number of pharmacies used 38 
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The use of certain drugs compared to others (discussed in text) 25, 39, 40 
Time in chronic usage 41 
Increasing dosing 42,43 
Having no medication review by a doctor in last 6 months 44 
(ii) Related to person  
Forgetfulness, Low cognition skills, low health literacy, and/or dementia 44, 45, 46, 47   
Having co-existing depression 48,49,50,51 
Vision loss/unable to read prescription label 2,52 
Arthritis in the arms 2 
On discharge from hospital 53,54 
The opinion that the medicine is not needed 2 
Problem drinking 44 
Being unmarried 44  
Resisting care 44 
 
 
Table 2: Characteristics, other than cost, which increase adherence 
 
Adherence increases with Reference/s 
Increasing label font size 2 
The use of calendars/charts/blister packs 55,56 
Cues (clock time, meal time, daily ritual) 57 
Increasing risk factors/ severity of disease 25,58,59,60 
Increasing knowledge of the disease 2,37 
Living with a relative/spouse support 61,62,63 
Belief in the medicine’s ability to cause improvement 64,65 
Belief in the physician 66 
 
Adherence is increased with the use of certain drugs compared to others.  For instance, 
adherence is higher to statins than cholestyramine,[25] and adherence in the older-aged with 
hypertension is greater to angiotensin converting enzyme inhibitors and calcium channel blockers 
than to β-blockers and diuretics.[39]  In glaucoma, adherence to latanoprost is higher than to other 
medications for glaucoma (e.g. β-blockers and α-adrenoceptor agonists).[40] 
 
Race may be a determinant of adherence in the older-aged, with some studies showing medicine 
adherence is higher in the white than non-white population.[35,66,67]  Most studies have shown that 
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adherence to medicines is similar in older-aged men and women.[66]  However, recent studies 
suggest that older-aged women are a little less likely to be adherent than men.[41,67] 
 
Pharmacists and community nurses have a major role in adherence, as the communication 
between the health professional and older-aged people is probably paramount to increasing 
adherence, and the subject’s health.  In an attempt to improve adherence, there have been 
several studies of interventions involving an allied health professional discussing adherence, but 
only a minority of these involve older-aged adults, and these are discussed in the following 
sections.  
 
 6.  Counselling by telephone  
 
Re-enforcement of the initial consultation with the doctor, with a follow-up telephone call from an 
allied health professional (pharmacist or nurse) may be a simple way to improve adherence.  This 
has been known since 1992, when telephone counselling, after a combination of education and 
medicine review, by the clinic nurse was shown to improve adherence.[68]  This study was 
undertaken over 4-6 weeks in a general medicine clinic in 70 subjects, with a mean age of 72 
years.[68]  The interventions were a 20 minute teaching session with a review of medicines with or 
without a follow-up telephone call.[68]  Without the telephone call, the increase in adherence was 
not significantly different from the control group (no intervention).[68]  However, with a telephone 
call, there was a significant increase in adherence.[68]  One criticism of this study is that the levels 
of adherence were not the same at the start of the study and, thus the study needs confirmation.   
 
Similar results have been obtained from a better controlled short-term study involving a telephone 
call from a pharmacist.  In this study, 500 subjects (mean age 67 years) who were receiving their 
first prescription for a new drug for a chronic conditions were randomised to usual care or the 
intervention.[69] The intervention was a structured interview including adherence, delivered by a 
trained community pharmacist.[69] At a 4-week follow up, adherence was 91% in the intervention 
group, compared to 84% in the usual care group.[69]  However, the number of subjects reporting 
medicine-related problems was also higher in the usual care group (34%) than the intervention 
group (23%)[69], and this, rather than the intervention, may explain the difference in adherence. As 
this study, and the one described in the previous paragraph, were short-term, they do not provide 
any information on whether counselling by a allied health professional using the telephone will be 
effective long-term. 
 
A small study of 50 subjects with heart failure living in the community has also shown that 
telephone counselling by a nurse is effective short-term.  This study enrolled subjects with a 
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mean age of 74 years, and showed that adherence to medicines dropped from 81% to 57% over 
2 months in the control group, but was maintained in the groups contacted by telephone or 
videotelephone daily with a brief greeting followed by being asked whether they had taken their 
medicine the previous day.[70]  Thus, videotelephoning had no advantage over regular phone 
reminders over this short period.[70]   
 
Importantly, one recent study has shown that telephone counselling can improve adherence long-
term to reduce clinical outcomes. In this study, telephone counselling was by a pharmacist to the 
older-aged outpatients receiving polypharmacy (≥ 5 medicines).[71]  This trial recruited 502 
subjects, with a mean age of 71 years, who were either adherent or not adherent to medicines at 
screening, and randomised them to telephone counselling or not.[71]  The telephone intervention 
was a 10-15 minute call from the pharmacist at the midpoint between clinic visits for two years.[71]  
In the telephone counselling intervention group, the 81% of the subjects who were adherent at 
the start of the study remained adherent, whereas only 7% of the non-adherent at enrolment 
remained non-adherent.[71]  In the control group, 58% of the adherent remained so, and 18% of 
the non-adherent continued to be non-adherent.[71]  Most importantly, this study showed that 
improving adherence decreased mortality.[71]  Thus, at the end of the two years, the mortality was 
11% in the intervention group, compared to 17% in the control group.[71]   
 
Telephone intervention has been shown to be more effective than mail intervention, but mail 
intervention does cause improvement in adherence.  In the study showing this, subjects (n = 636) 
with a mean age of about 61 years, and newly diagnosed hypertension or uncontrolled 
hypertension, on standard treatment, were randomised to control, mail intervention, or telephone 
intervention.[72]  The mail intervention group received information about all aspects of 
hypertension, while the telephone intervention group had a nurse phone and assess adherence, 
and then congratulate good adherers and encourage non-adherers.[72]  Adherence at 6 months 
was 69.2% in the control group, 91.3% in the mail intervention group, and 96.2% in the telephone 
intervention group.[72]  Blood pressure falls during the 6 months were greater with the telephone 
intervention than in the mail intervention and control groups.[72]   
 
Counselling by telephone did not work when the adverse effects were the cause of the non-
adherence in subjects with hypercholesterolemia.  Thus, the adverse effects of niacin or the bile 
sequestants reduces adherence to these drugs in 60 year olds, telephone calls did not improve 
adherence.[73]  Fortunately, medicines with better tolerability than niacin/bile sequestants have 
become available for the treatment of hypercholesterolemia, and this removes adverse effects as 
a barrier to adherence in this condition.   
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Counselling by telephone does not work when the adherence is already high.  However, in the 
long-term, the counselling may be beneficial, but this has only been demonstrated in a small 
study of high risk subjects.  Thus, in 30 subjects (mean age ~62 years) who had just undergone 
cardiac surgery, telephone counselling with a pharmacist, did not improve the adherence to either 
lovastatin or colestipol, which was about 90% for each drug after 12 weeks, with and without 
telephone counselling.[74]  The telephone counselling was stopped after 12 weeks.[74]  After one 
year the adherence to lovastatin and colestipol was 71% and 54% for those that had had 
counselling, compared to 47% and 27% in those not counselled, respectively.[74]  After, 2 years 
the difference was still apparent, with adherence to lovastatin and colestipol being 63% and 48% 
with previous counselling, and 39% and 23%, respectively without counselling.[74]  
 
 7. Face-to-face counselling 
  
7.1 At the pharmacy 
It is debateable as to whether face-to-face counselling at the pharmacy improves adherence to 
medicines in the older aged.  In one study, on discharge from hospital, all 706 subjects (mean 
age 74 years taking a mean of 6 medicines each) were provided, by the pharmacist, with a book 
to record medical information, such as drug purpose, dosage, and schedule.[75]  In addition, the 
intervention group had a face-to-face meeting with the pharmacist at the hospital pharmacy.[75]  At 
this meeting, the pharmacist discussed the purpose and use of the medications and potential 
drug-related problems, and this was followed up at 1 week, 2-4 weeks, 2 months, and 3 months 
post-discharge by consultations, usually by telephone.[75]  Adherence was very high in this study, 
and at 3 months was over 95% in the control and intervention group.[75]  As adherence was 
measured by structured telephone interviews in this study, it would have been susceptible to 
recall bias and intentional misrepresentation.[75]  Alternatively, the book to record medical 
information may have induced the good adherence. 
 
A large international study, which included adherence in the pharmaceutical intervention, was 
unable to show any benefit with the intervention in total, including in adherence, over 18 
months.[76]  The study recruited over 2,000 subjects, 65 years or older, taking 4 or more 
prescribed drugs, who were community dwelling and regular visitors to the community 
pharmacy.[76]  The intervention pharmacists were trained to assess subjects and to educate the 
subjects on the drugs, implement adherence-improving strategies, and to rationalise and simplify 
drug regimens.[76]  There were many problems with the implementation of this protocol in various 
countries, and no definite findings emerged.[76]  An interview-based questionnaire indicated that 
the intervention had not improved adherence.[76]  The results of this study suggest that, this type 
 13
of pharmacist intervention does not have a major effect on adherence, as a large study should 
have been able to pick up any significant changes.   
 
Two studies have shown there is small improvement in adherence in the older aged with heart 
failure with face-to-face counselling at the pharmacy.  In the first study, the 152 subjects with 
heart failure had a mean age of 70 years old, and adherence to loop diuretics was measured.[77]  
In the intervention group, on the first visit to the community pharmacy, the pharmacist used a 
computerized medication history to discuss drug use, reasons for non-adherence, and to 
reinforce medication adherence.[77] Pharmacists then contacted the subjects in the intervention 
group on a monthly basis for up to 6 months.[77] After 6 months, the percentage of adherent days 
was higher in the intervention group (98.2%) than in the usual care group (94.6%).[77] In this 
study, the adherence in the usual care group was much higher than expected (50% in heart 
failure), probably because most of the subjects were also visiting a specialized heart failure clinic, 
and because of the notable symptomatic relief that subjects with heart failure have with loop 
diuretics.[77] 
 
Although this improvement in adherence in heart failure with a pharmacist was confirmed 
recently, it was also shown that the improvement was lost once the intervention has stopped.  
This was shown in a recent trial of 314 low-income subjects (mean age 63 years) with heart 
failure.[78]  Subjects were randomised to normal care or had the intensive intervention of a 
pharmacist for 9 months.[78]  In the normal care group, when the medicines were dispensed, the 
pharmacist provided patient-centred verbal instructions and written materials about the 
medicines.[78]  In addition, in the intervention group, the pharmacist monitored the patients’ 
medicine use, health care encounters, body weight and other data, and conveyed the information 
to an interdisciplinary team of investigators (including physician, clinic nurses), who helped with 
the pharmacist intervention.[78]  The intervention of the pharmacist increased the adherence rate 
at the end of the 9 months (78.8% vs 67.9%).[78]  Emergency department visits and hospital 
admissions were 19.4% less, and annual direct health care costs including those for the 
intervention were lower, in the intervention than normal care group.[78]  Unfortunately the 
improved adherence was lost 3 month post-intervention (70.6% vs 66.7%).[78]  This suggests that 
an ongoing intensive intervention is required to achieve continued good adherence. 
 
 7.2 During a home visit  
Face-to-face counselling visits have been shown to improve adherence in the older aged in some 
situations but not all.  For instance, a study of counselling with a pharmacist in 362 older aged 
(mean age 84 years), who were taking 4 or more medicines, did not show any improvement in 
adherence.[79]  In this study, at the discharge from hospital, control subjects were discharged from 
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the hospital following standard procedures.[79]  In the intervention group, a pharmacist rationalized 
the medicines on discharge, and this was followed by a visit from the community pharmacist 7-14 
days after discharge who counselled the subjects on adherence.[79]  Adherence in the control 
group was 75% at baseline, declined to 52% at 3 months, and 45% at 6 months, and this 
adherence was not altered by the intervention from the pharmacists.[79]  Given the similar 
adherence between groups, it was not surprising that there was no difference between groups in 
clinical outcomes such as re-admission to hospital and death.[79]   
 
However, face-to-face counselling visits have been shown to improve adherence in the older 
aged with heart failure.  A hundred subjects (mean age 84 years old) with chronic stable heart 
failure, who took responsibility for their own medications were recruited from an outpatient’s 
clinic.[80]  All of the subjects were visited 4 times by the pharmacist at 2-4 weekly intervals, but 
only the intervention group were give counselling on adherence.[80]  Adherence remained constant 
over the 3 months in the control (baseline, 49%; 3 months, 50%), but improved in the intervention 
group (baseline, 61%; 3 months, 93%).[80]  Associated with this improved adherence, there was 
improved knowledge of the medicines, greater exercise tolerance, and improved peripheral and 
pulmonary oedema scores.[80]  A criticism of this study is that the levels of adherence were not the 
same in the two groups at the start of the study and, thus the study needs confirmation. 
 
 8. Education program 
  
 8.1 Alone 
A 1990 in-hospital study to determine whether brief education on the medicines would improve 
adherence on discharge, did not show any effect in the older-aged.[81]  The 258 subjects enrolled 
in the study had a mean age of 69 years, and were taking 4-5 drugs each.[81]  The topics of the 
medicine education program were names and strengths of drugs, the importance and reasons 
behind directions for use, how to store and read expiry dates, and avoiding drug interactions.[81]  
This was followed by 15 minutes of pre-discharge individual counselling.[81]  The control 
intervention was a general health education program “Getting Older. Feeling Better”, led by a 
Nurse Educator, which did not include discussions of medicine.[81]  After discharge, but there was 
a high drop out in both groups (~40%), which may have distorted the results.[81]  Those who 
stayed in the study had high adherence, with 93% and 96% in the control and medicine education 
program being adherent at 1 month, and 89% and 93% at 3 months, respectively.[81]  One 
interpretation of these results could be that a general health education program is as good as a 
specific medicine education program in promoting adherence, and this should be tested.  It would 
have been of interest to know whether these high rates of adherence were retained beyond the 3 
months. 
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A small but longer study of an intervention with a pharmacist suggests that education may 
improve adherence.  In this study, in rural Alabama, 69 subjects with a mean age of 65 and 
chronic health problems were randomised to control group or an intervention group.[82] The 
intervention occurred when they visited the clinic for an appointment with a physician, and 
included the pharmacist providing subject-specific drug education, and applying adherence-
enhancing strategies.[82] In this study, an adherence subject used ≥ 80% of their medicines, and 
at 12 months, full adherence was observed in the intervention group compared to 89% in the 
control group, but with the small number of subjects, this was not a significant difference.[82] 
Hospitalizations and emergency department visits decreased in the intervention but not the 
control group, but this may represent a difference in disease state at baseline, as the intervention 
group had more hospitalization/emergency department visits than the control group, prior to 
randomisation, rather than due to improved adherence.[82] In addition to size, a major limitation to 
this study, is that it is of subjects who were visiting the clinic, and not a sample of the population. 
 
In contrast, education emphasizing adherence has been shown to be effective short-term when it 
is specifically directed at hypertension.  In an old study (1980), of 52 subjects (mean age 55 
years) that were not being adherent, extended education with a nurse and psychologist was 
shown to be more effective than a nurse educator alone in improving adherence at 8 weeks.[82]  In 
the control, nurse-operated hypertension clinic, during the weekly visits, the nurse measured 
blood pressure and adjusted medicine, and the subjects watched video tapes with hypertension 
information.[83]  In the experimental group, the session was twice as long (90 minutes) with the 
psychologist and nurse sought to create an atmosphere of individual responsibility and the topics 
discussed were perception of the disease as serious, belief in the effectiveness of treatment, and 
satisfaction with the treatment.[83]  At 8 weeks, adherence was greater with the extended 
education, and this was associated with a decrease in blood pressure.[83]  The decrease in blood 
pressure with the extended education was maintained after 3 and 7 months,[83] indicating that 
adherence may have continued, but unfortunately this was not measured. 
 
A multifactorial health-education specifically for subjects with hypertension has also been shown 
to enhance adherence. This study enrolled 435 subjects with hypertension and a mean age of 
about 56 years.[84]  In the experimental group, subjects received an enrolment kit containing a 30-
day supply of atenolol, an education newsletter about hypertension, and information on nutrition 
and life-style changes.[84]  Before the next scheduled prescription-refill date, subjects in the 
experimental group received a telephone call from a pharmacist, which included stressing the 
importance of adherence.[84]  Prescription-refill reminders were then mailed at monthly intervals.[84]  
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After 6 months, the medicine possession ratio was much higher in the education group versus the 
control group.[84]   
 
A recent study in 84 older subjects (mean age ~ 64) with overactive bladder shows that an 
education program was effective for non-drug treatments, but the results with medication 
adherence were not clear cut.[85] In this study, the intervention was delivered by a physician or the 
study nurse, who briefly reviewed the information sheets with the subject with overactive bladder, 
whereas the control group had normal care.[85] This intervention was clearly effective at promoting 
non-drug treatments (pelvic floor exercises, bladder stretching, urge suppression, regulation of 
fluid intake etc), but did not significantly improve adherence to medication (tolterodine).[85] At 
baseline, the adherence to tolterodine was higher in the intervention group (97%) than the control 
group (82%), and declined to 38% in the intervention group and 31% in the control group, at week 
16.[85] 
 
 8.2 In combination with ongoing counselling 
The combination of an education program with counselling does improve adherence over the use 
of an education program alone.  In the Medicine Use Study, the pharmacists at the intervention 
site were supplied with a videotape, patient information leaflet and newsletters on hypertension, 
congestive heart failure and raised cholesterol to help with their counselling, whereas the other 
site used usual counselling.[86]  All subjects, who had a mean age of 61 years, were subsequently 
telephoned three times over eight months, and asked a series of health questions including 
whether they were taking their medications.[86]  Adherence was good in both groups, but was 
higher for new patients taking statins or ACE inhibitors who had the counselling including the 
videotape (statins, 92% vs 79%; ACE inhibitors, 95% vs 87%).[86]   
 
In the Federal study of Adherence to Medicines in the Elderly (FAME), 200 older-aged subjects 
(mean 78 years old), taking at least 4 chronic medicines (92% had hypertension, 81% had 
hyperlipidemia), had a 6 month intervention pharmacy care program, and this produced an 
adherence rate of 97%.[87]  The pharmacy care program consisted of medicine education with 
standardized scripts, 2-monthly follow-up by clinical pharmacists, and medicines dispensed in 
time-specific packs for 6 months (blister packs).[87]  This high rate of adherence was associated 
with a 3.3 mmHg decrease in systolic blood pressure, and a 4.9 mg/ml decrease in LDL 
cholesterol.[87]  The subjects were then randomised to usual care or continued intervention from 
the pharmacists for 6 months.[87]  In the usual care group, the adherence fell to 69%, whereas in 
the pharmacist intervention group, it remained very high (96%).[87]  During this six months, blood 
pressure decreased further in the pharmacists intervention group (-6.9 mmHg) than in the usual 
care group (-1.0 mmHg).[87]   
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 8.3 In combination with a medicine review 
The combination of medicine review and various education programs may improve adherence to 
medicines in the older aged short-term.  In a group of 80 year olds, hospitalized for heart failure, a 
combination of a medicine education program delivered by the study nurse (including the 
importance of adherence), dietary advice from a dietician, and a medicine review by the 
cardiologist prior to discharge led to an improvement in short-term adherence after discharge 
(88% vs 81%, at 30 days).[88]   
 
A combination of a medicine review and education program by a clinical pharmacist has been 
shown to increase the adherence to medicines in older-aged people in general practice taking at 
least 3 medicines.[89]  Each group had 3 visits by the pharmacist, and the differences were that the 
intervention group had their medicines rationalized at the first week, and were given medicines 
education at the second visit.[89]  Adherence was 79.5% in the control group and this was 
improved to 91.3% after 2 months by the intervention, and this improvement was associated with 
a greater understanding of the purpose of their medicine by the subjects.[89]   
 
9. Future directions for allied health professional interventions to improve adherence 
 
In chronic medical conditions, adherence to medicines is a worldwide problem.  In the older-aged, 
it is a common cause for hospital and residential care admissions, and for the progression of 
disease.   It seems likely that improving adherence would cut the costs of these, and of medicine 
wastage.  Indeed, reduced costs with increasing adherence have already been demonstrated in 
diabetes,[13]  and overactive bladder syndrome.[22]   
 
 9.1 Based on present studies 
Some types of intervention using allied health professions have been shown to improve 
adherence in the older aged (counselling by telephone, face-to-face counselling, and education 
on the medicine being used).  However, many of these strategies have only been evaluated in 
trials with small numbers of subjects over short periods.  Thus, there is a need for evaluations of 
interventions in much larger populations of the older-aged over longer periods.   
 
One study has shown that when the intervention is stopped, the adherence reverts to the level of 
the control group[78], whereas another small study, suggests that the intervention can be effective 
after it has stopped.[74]  However, most of the studies using intervention to improve adherence in 
the older-aged have not considered the duration of the effectiveness of the intervention after the 
intervention stops.  For instance, can an intensive short term intervention by an allied health 
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professional be used to improve adherence long term?  Alternatively, is low key continuing 
intervention effective long term?  Also, do some medical conditions need continued intervention 
to improve adherence, and others not?  All of these questions need testing in clinical trials. 
 
It is also not clear whether any of the interventions by allied professionals shown to be effective in 
clinical trial have evolved into standard practice and shown to be effective.  Thus, studies 
evaluating these interventions in standard practice need to be undertaken, and reported.  
Strategies to implement successful interventions into standard practice also need to be 
considered. 
 
  9.2 Comparison studies 
The interventions tested to improve adherence in the older-aged range from a minor modification 
of standard practice to a major interventions. However, there are few (if any) studies comparing 
the efficacy of different interventions.  Thus, we do not know which is the best intervention, and 
whether this is the same or different for each group of people or each chronic disease.  Thus, 
studies comparing different interventions by allied health professionals should be undertaken for 
the general population of older-aged, and for sample populations with each chronic disease. 
 
 9.3 Cost 
Although interventions by allied health professionals to improve adherence are probably cost 
effective as they keep the older-aged out of hospital and residential care, this has not been 
shown directly to date for all chronic conditions.  Also, there has been little analysis of the cost 
benefit of the different interventions by allied health professionals to determine which is the most 
cost effective in the older-aged.  Thus, more cost effective analysis of interventions and between 
interventions should be undertaken. 
 
Without studies directly showing any cost benefit in most chronic conditions, one perceived 
drawback to the use of interventions is the cost of the allied health professional’s time to the 
employer (government).   Thus, to make interventions appealing to health authorities, it may be 
necessary to limit the time the allied health professional spends on each subject or to limit the 
number of subjects to keep costs as low as possible.   
 
 9.4 Targeting intervention for adherence studies to high need groups 
One way to do limit the number of the older-aged, subjected to allied health professional 
intervention, may be to target groups that are in need of special attention.  For instance, an 
adherence audit could be undertaken after 3 months of treatment with a medicine for a chronic 
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condition, and then the older-aged who were non-adherent could be targeted by the allied health 
professional for studies to improve adherence.   This approach has not been tested to date. 
 
Alternatively, the older-aged could be grouped into those that do and do not require intervention 
by demographics.  For instance, it is unlikely that the older-aged living in residential care or with a 
carer need intervention to promote adherence, as their adherence will be looked after by others.  
In contrast, the older-aged struggling to live alone may need the intervention of an allied health 
professional to promote their adherence.   Thus, studies need to be undertaken to further 
characterise the older aged who are non-adherent. Subsequently, intervention studies by allied 
health professionals can be undertaken that target the non-adherent to improve their adherence. 
 
One group, which has already been shown to have lower adherence, is the older-aged with low 
socio-economic status. Thus, studies have shown that those who have to pay for medicines out 
of pocket are more likely to be non-adherence.[26,27]  However, there have been no studies to 
determine whether interventions are more or less effective in the lower than higher socio-
economic states, and such studies should be undertaken.  Also, there are no studies of 
intervention strategies by allied health professional that particularly target the adherence of the 
older-aged in the lower socio-economic states.  New interventions strategies may be necessary 
for the low socio-economic status e.g. interventions that reduce the cost of the medicine.   For 
instance, if the subject maintains adherence over 3 months, perhaps the fourth month of 
medicines could be provided free.  Interventions promoting the use of generic drugs may also be 
useful in making medicines more affordable to those with low socio-economic status. 
 
 9.5 Conclusions 
In conclusion, although we assume that the intervention of an allied health profession will improve 
adherence to medicines in the older-aged with chronic conditions, there is limited evidence to 
support this.  There are many unanswered questions about the most effective, and the most cost 
effective interventions, for improving adherence in the older-aged.   More studies are needed to 
determine appropriate interventions by allied health professions, and these need to consider 
intensity of intervention, duration of intervention, disease status, and demographics.  While these 
studies are being undertaken, it should be remembered that some of the present interventions 
with a health professional have been shown to be effective, and these should be introduced and 
used in practice.   
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